Markets:

Overview

News

Currencies

International

Treasuries

GoodRx Holdings, Inc. - Class A Common Stock (NQ:GDRX)

3.129 +0.079 (+2.59%)

Streaming Delayed Price Updated: 11:54 AM EDT, Jul 28, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about GoodRx Holdings, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

22 23 Next >

GoodRx Appoints Healthcare Industry Veteran, Wendy Barnes, as New Chief Executive Officer

December 16, 2024

From GoodRx Holdings, Inc.

Via Business Wire

Novo Nordisk's Ozempic Label Expansion Snags Approval From European Drug Regulator's Advisory Panel ↗

December 12, 2024

Novo Nordisk's Ozempic gains positive EMA opinion for label update after FLOW trial data show significant kidney and cardiovascular risk reduction.

Via Benzinga

How Much Did Americans Overspend On Weight Loss Medications in 2024? GoodRx Reveals ↗

December 05, 2024

GoodRx's latest research shows surging demand for weight loss medications like Wegovy and Zepbound, despite high costs and limited insurance coverage, with consumers overspending $200 million in 2024.

Via Benzinga

GoodRx Reveals Americans Overspent on Weight Loss Medications by $200 Million This Year, Fills Still Surged

December 05, 2024

From GoodRx

Via Business Wire

GoodRx Holdings Stock: A Deep Dive Into Analyst Perspectives (6 Ratings) ↗

August 16, 2024

Via Benzinga

GOODRX ALERT: Bragar Eagel & Squire, P.C. is Investigating GoodRx Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

November 12, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

Why GoodRx Holdings Stock Was Sinking This Week ↗

November 08, 2024

The company is growing key fundamentals. However, the improvements weren't enough to impress the market.

Via The Motley Fool

GoodRx (GDRX) Q3 2024 Earnings Call Transcript ↗

November 07, 2024

GDRX earnings call for the period ending September 30, 2024.

Via The Motley Fool

Topics Earnings

GoodRx Reports Third Quarter 2024 Results

November 07, 2024

From GoodRx Holdings, Inc.

Via Business Wire

GoodRx to Participate in Upcoming Investor Conferences

November 04, 2024

From GoodRx Holdings, Inc.

Via Business Wire

GoodRx Unveils New E-commerce Platform, Launches with Opill®

October 31, 2024

From GoodRx

Via Business Wire

GoodRx Announces Exclusive Low Cash Price for QSYMIA®, the Leading Branded Once-Daily Oral Weight Management Medication for Adults

October 29, 2024

From GoodRx

Via Business Wire

Ronald E. Bruehlman Joins GoodRx Board of Directors

October 28, 2024

From GoodRx

Via Business Wire

GoodRx Announces New Affordability Programs for Menopause Hormone Therapies

October 23, 2024

From GoodRx

Via Business Wire

GoodRx Partnering with Retail Pharmacies to Deliver Pay-Over-Time Option Directly to Consumers

October 16, 2024

From GoodRx

Via Business Wire

GoodRx Announces Date for Third Quarter 2024 Earnings Release and Conference Call

October 10, 2024

From GoodRx Holdings, Inc.

Via Business Wire

GoodRx Announces Lowest Discounted Cash Price at Retail Pharmacy Locations for neffy® (epinephrine nasal spray)

September 26, 2024

From GoodRx

Via Business Wire

GOODRX ALERT: Bragar Eagel & Squire, P.C. is Investigating GoodRx Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

September 25, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

GoodRx to Participate in Upcoming Investor Conferences

August 21, 2024

From GoodRx Holdings, Inc.

Via Business Wire

GoodRx (GDRX) Q2 2024 Earnings Call Transcript ↗

August 08, 2024

GDRX earnings call for the period ending June 30, 2024.

Via The Motley Fool

Topics Earnings

GoodRx Reports Q2 Earnings With Increased Prescription Revenue But Subscription Challenges ↗

August 08, 2024

GoodRx reported Q2 revenue of $200.61M, a 6% YoY increase. Prescription transactions revenue rose 7%, driven by 8% growth in Monthly Active Consumers. The company expects FY 2024 revenue at the lower...

Via Benzinga

GoodRx Reports Second Quarter 2024 Results

August 08, 2024

From GoodRx Holdings, Inc.

Via Business Wire

MicroStrategy, Coinbase, Robinhood, Tesla And Other Big Stocks Moving Higher On Monday ↗

July 15, 2024

Via Benzinga

GoodRx Announces Date for Second Quarter 2024 Earnings Release and Conference Call

July 11, 2024

From GoodRx Holdings, Inc.

Via Business Wire

Ian T. Clark Joins GoodRx Board of Directors

July 10, 2024

From GoodRx Holdings, Inc.

Via Business Wire

3 Lawsuit-Laden Stocks to Dump Before Problems Multiply ↗

July 10, 2024

These stocks to sell face ongoing and past litigation, but that isn't the only sticking point in their long-term prospects.

Via InvestorPlace

Market Correction Alert: Sell These 3 Tech Stocks While You Can ↗

June 28, 2024

These tech stocks to sell combine shaky operational outlooks with underlying fundamental shakiness that don't bode well for the long-term.

Via InvestorPlace

GoodRx Launches New “Prescription Cost Tracker” to Spotlight Key Factors Driving Out-of-Pocket Medication Costs in the U.S.

June 26, 2024

From GoodRx

Via Business Wire

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of GoodRx

June 21, 2024

From Faruqi & Faruqi LLP

Via GlobeNewswire

GDRX Investors Have Opportunity to Lead GoodRx Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm

June 21, 2024

From The Schall Law Firm

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9

...

22 23 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.